Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Efficient N-acylindole production via alkenyl carboxylates. High selectivity, metal-free, scalable for pharma intermediates.
Patent CN108752256A reveals base-catalyzed N-acylation. Offers high selectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel nickel-catalyzed asymmetric Kumada coupling method for high-purity profen intermediates. Reduces catalyst loading and improves scalability for pharmaceutical manufacturing.
Patent CN110004081A details a novel biocatalytic route for gamma-lactam. This method ensures high optical purity and offers significant supply chain cost reduction advantages.
Patent CN115851559A reveals a novel recombinant E. coli route for 3,4-DHBA. Discover cost-effective biosynthesis solutions and supply chain advantages for chiral intermediates.
Patent CN114958938B reveals enzymatic synthesis for Paxlovid intermediate. Offers high yield and cost reduction for pharmaceutical intermediate supply chains.
Patent CN111763209B details a novel Ruxolitinib synthesis avoiding expensive catalysts. Discover cost reduction in API manufacturing and high-purity pharmaceutical intermediates.
Novel antitumor intermediate synthesis via condensation. Low toxicity, high purity scalable route for pharmaceutical manufacturing and drug development.
Patent CN105906523B details a green Zoalene synthesis method reducing waste acid by 90% and ensuring high-purity veterinary drugs for global supply chains.
Advanced copper-catalyzed process for heteroaromatic BTK inhibitor intermediates ensuring high yield, mild conditions, and scalable supply chain reliability for global pharma.
Patent CN102964334B details a novel Heck-reduction route for 2-thiopheneethanol, offering mild conditions and high purity for cardiovascular drug intermediates.
Patent CN115197144A details silver-mediated cyclization for high-purity pharmaceutical intermediates. Offers cost reduction in manufacturing and scalable supply chain solutions.
Discover advanced mycophenolic acid purification reducing Z-isomer impurities below 0.10%. Enhance supply chain reliability and pharmaceutical intermediate quality with our patented process.
Patent CN102399194A reveals a surfactant-assisted neutral hydrogenation process for TAHMS, offering significant cost reduction and purity improvements for pharmaceutical intermediate manufacturing.
Patent CN110862372A discloses a novel succinonitrile-based process for clopidogrel intermediates, offering superior optical purity and yield for reliable pharmaceutical intermediates supply chains.
Novel coumarin-based route for Vilazodone intermediate offers higher yield and scalable production for reliable pharmaceutical intermediates supplier partnerships.
Patent CN108794653B discloses synthetic fucosylated chondroitin sulfate clusters with defined structures. Offers cost reduction in anticoagulant manufacturing and reliable supply chain solutions.
Patent CN102363598B reveals pressurized acid hydrolysis for gabapentin. Reduces waste, improves yield, ensures supply chain stability for pharmaceutical intermediates.
Novel ribofuranose phosphate derivative method offers high purity and scalable production for Hepatitis C antiviral manufacturing supply chains reducing costs.
Novel one-pot synthesis of piperazinone-hydroxypyridone-5-carboxyl compounds via metal-free catalysis. Enhances supply chain reliability and reduces manufacturing costs for RNA polymerase inhibitors.